Ardigen CEO Janusz Homa Recognized Among AI Sector Leaders by Forbes Polska

Topic:

The theme of the latest issue of Forbes Polska (07/23) is artificial intelligence. The ranking included there could not miss the listing of Polish entrepreneurs involved in AI technology. Janusz Homa – CEO of Ardigen – received an honorable mention among them.

You can read the entire ranking here: https://www.forbes.pl/rankingi/ranking-firm-ai-polska-firma-z-orbity-obserwuje-co-rosjanie-robia-na-ukrainie-kolejna/dq5ewdv

Forbes Highlights the Importance of AI in Healthcare

At the forefront of the ranking its author, Filip Kowalik, writes:

“Our latest ranking of the best Polish companies developing solutions based on artificial intelligence algorithms indicates that the new technology should be approached without fear, but rather with hope. Indeed, the list is headed by companies that want to save human life and health.”

Thank you for the Recognition

At Ardigen, we share this optimistic view, dedicating our work to the betterment of human life and the condition of global healthcare services. The Forbes’ acknowledgment serves as a testament to the importance of tech innovations in the health and medical fields. 

We are grateful to Forbes Poland for this award and hope to put our hand to even more innovations and positive changes in the biotech industry in the future.

You might be also interested in:

BIO Convention 2025
BIO International Convention 2025 – New Standards in Collaboration, Innovation, and the Integration of AI in Biotechnology
Biologics 2.0 – From monoclonal antibodies to multispecific therapeutics
Computer Vision Meets Life Sciences: Inside the CVPR 2025 Workshop Co-Organized by Ardigen
High-performance computing servers powering biomedical data pipelines and drug discovery.
Beyond the Petabytes: What It Really Takes to Power the Next Leap in Drug Discovery

Contact

Ready to transform drug discovery?

Discover how one of the top AI CROs in the world, can be your trusted partner in revolutionizing drug discovery through AI.

Contact us today to learn more about our tailored solutions for empowering your drug development journey.

Send us a message and we will contact you back within 48 hours.

Newsletter

Become an insider

Be the first to know about Ardigen’s latest news and get access to our publications, webinars and more!